HIT Consultant has covered our collaboration between Ellison Medical Institute, led by cancer researcher Dr. David Agus. This partnership has already led to significant results, including a remarkable advancement in the performance of AlphaFold2.
Our success lies with our life sciences-focused AI workflow platform. The platform empowers scientists with tools that integrate the best available models while adapting to new advancements with ease. It allows for seamless collaboration, enabling researchers, oncologists, and biochemists to work closely together as they push the boundaries of drug design.
Dr. Agus highlights the impact of this partnership, stating that Salt’s innovations have accelerated the creation of new cancer therapies, making the process both faster and scalable.
Our venture into life sciences isn't just about technology—it's about transforming the way we tackle some of the world’s most pressing life sciences challenges.
